Stock listing

NASDAQ:RANI Rani Therapeutics Holdings, Inc. Stock

Home listing (NASDAQ) of Rani Therapeutics Holdings, Inc.

Follow Rani Therapeutics Holdings, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RANI

$0.547 USD +0.031 (+5.9%)

Close on Nov 6, 2026

Past year -75.9% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.528 – $0.547 USDNov 6, 2026
Volume
460,516 sharesNov 6, 2026
Market cap
$63.11M USDAt the close on Nov 6, 2026 · price × 115.4M shares outstanding
52-week range
$0.510 – $2.155 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$441,614 USDMedian day 464,358 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Rani Therapeutics Holdings, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RANI · Home$0.547 USD+0.031 (+5.9%)460,516$0.544$0.547$0.528$0.516Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:RANI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.547+0.031+5.9%$0.544$0.547$0.528460,516
$0.516-0.057-9.9%$0.584$0.584$0.510689,848
$0.573+0.017+3.1%$0.567$0.585$0.563285,565
$0.556+0.004+0.7%$0.560$0.602$0.550650,813
$0.552-0.038-6.5%$0.581$0.597$0.551412,363
$0.590-0.015-2.5%$0.600$0.605$0.573677,286
$0.605-0.010-1.6%$0.610$0.615$0.597405,702
$0.615+0.006+1.0%$0.608$0.618$0.598326,334
$0.609-0.008-1.3%$0.623$0.630$0.600327,692
$0.617+0.011+1.8%$0.620$0.630$0.586300,891
$0.606+0.018+3.1%$0.598$0.615$0.590288,100
$0.588-0.017-2.8%$0.620$0.629$0.574770,100
$0.605-0.048-7.4%$0.655$0.655$0.603688,100
$0.653+0.003+0.5%$0.660$0.680$0.641456,400
$0.650+0.009+1.4%$0.638$0.657$0.633457,600
$0.641-0.039-5.7%$0.686$0.698$0.635589,200
$0.680+0.010+1.5%$0.665$0.694$0.650450,200
$0.670-0.063-8.6%$0.714$0.750$0.6651,196,000
$0.733-0.018-2.4%$0.750$0.766$0.710918,700
$0.751-0.048-6.0%$0.790$0.803$0.750431,000
$0.799+0.007+0.9%$0.801$0.818$0.790235,500
$0.792-0.020-2.5%$0.801$0.836$0.785451,300
$0.812-0.017-2.1%$0.813$0.837$0.790232,200
$0.829+0.054+7.0%$0.797$0.830$0.780954,300
$0.775-0.036-4.4%$0.840$0.840$0.770582,000
$0.811+0.015+1.9%$0.808$0.830$0.798418,300
$0.796+0.005+0.6%$0.819$0.852$0.791484,000
$0.791-0.009-1.1%$0.810$0.821$0.780468,200
$0.800+0.024+3.1%$0.800$0.822$0.778405,600
$0.776+0.017+2.2%$0.760$0.800$0.740624,600
$0.759+0.010+1.3%$0.755$0.775$0.731382,600
$0.749-0.018-2.3%$0.777$0.786$0.749607,000
$0.767-0.011-1.4%$0.810$0.810$0.767648,600
$0.778-0.011-1.4%$0.800$0.830$0.775651,600
$0.789-0.073-8.5%$0.864$0.870$0.789677,800
$0.862+0.010+1.2%$0.850$0.862$0.820383,000
$0.852+0.096+12.7%$0.759$0.862$0.759663,700
$0.756-0.066-8.0%$0.810$0.840$0.7551,437,900
$0.822-0.014-1.7%$0.834$0.849$0.794733,700
$0.836-0.007-0.8%$0.850$0.859$0.831372,400
$0.843+0.021+2.6%$0.850$0.854$0.830312,200
$0.822-0.018-2.1%$0.850$0.850$0.822187,900
$0.840-0.033-3.8%$0.878$0.879$0.839315,600
$0.873+0.008+0.9%$0.873$0.897$0.860531,300
$0.865+0.013+1.5%$0.858$0.882$0.852380,700
$0.852-0.006-0.7%$0.860$0.870$0.840392,000
$0.858-0.007-0.8%$0.852$0.879$0.837426,500
$0.865+0.011+1.3%$0.850$0.902$0.8441,155,600
$0.854+0.014+1.7%$0.858$0.870$0.836382,600
$0.840-0.014-1.6%$0.860$0.861$0.836371,400
$0.854+0.013+1.5%$0.840$0.868$0.840312,000
$0.841-0.050-5.6%$0.878$0.890$0.841531,500
$0.891+0.012+1.4%$0.890$0.896$0.860782,316
$0.879-0.001-0.1%$0.890$0.890$0.840471,822
$0.880+0.029+3.4%$0.879$0.897$0.860706,100
$0.851-0.066-7.2%$0.862$0.900$0.850769,600
$0.917+0.092+11.2%$0.811$0.928$0.8021,363,400
$0.825+0.029+3.6%$0.810$0.890$0.7522,632,600
$0.7960.0000.0%$0.810$0.816$0.775469,400
$0.796-0.002-0.3%$0.781$0.820$0.771889,200
$0.798-0.005-0.6%$0.810$0.820$0.775374,000
$0.803+0.018+2.3%$0.774$0.824$0.774539,100
$0.785+0.008+1.0%$0.778$0.808$0.770323,562
$0.777-0.015-1.9%$0.804$0.804$0.764338,666
$0.792+0.011+1.4%$0.785$0.800$0.782202,100
$0.781+0.001+0.1%$0.788$0.814$0.779696,100
Ticker
NASDAQ:RANI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Rani Therapeutics Holdings (NASDAQ:RANI) Q4 2025 Earnings Call

    Thu, Mar 26, 2026 · 4:30 PM ET

    Watch Transcript

  • Rani Therapeutics Holdings (NASDAQ:RANI) Q4 2024 Earnings Call

    Mon, Mar 31, 2025 · 4:30 PM ET

    Watch Transcript

  • Rani Therapeutics Holdings (NASDAQ:RANI) Q4 2023 Earnings Call

    Wed, Mar 20, 2024 · 4:30 PM ET

    Watch Transcript

Latest news

Rani Therapeutics to Participate in the Chardan Healthcare Conference

Oct 13, 2026

Closed $0.67 (-8.6%) on Oct 14, 2026

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Oct 5, 2026

Closed $0.775 (-4.4%) on Oct 5, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Sep 8, 2026

Closed $0.873 (+0.9%) on Sep 8, 2026

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

Aug 13, 2026

Closed $0.796 (-0.3%) on Aug 14, 2026

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

Aug 4, 2026

Closed $0.82 (+2.4%) on Aug 4, 2026

Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jul 20, 2026

Closed $0.691 (+0.7%) on Jul 21, 2026

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Jul 15, 2026

Closed $0.677 (+4.3%) on Jul 15, 2026

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates

Jul 9, 2026

Closed $0.687 (-1.6%) on Jul 10, 2026

Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer

Jun 29, 2026

Closed $0.765 (+3.9%) on Jun 29, 2026

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

May 26, 2026

Closed $0.941 (-12.1%) on May 26, 2026

All Rani Therapeutics Holdings, Inc. news

Financings

  • Private placement of private placement

    Oct 23, 2025

    Closed: US$60.3M raised · US$0.48 a share · Warrants at US$0.48 for 60 months · H.C. Wainwright & Co. +1

    Dealers: H.C. Wainwright & Co. (lead), Maxim Group LLC (co-lead)

    Buyers: Samsara BioCapital (led the private placement); RA Capital Management; Anomaly (Right to designate one board member); Special Situations Funds; Invus; Mir Imran (Executive chairman; bought at a combined price of $0.605 per share and accompanying warrant); Samsara; Mr. Imran (purchased at a combined purchase price of $0.605 per share and accompanying Warrant); Samsara BioCapital, L.P. (Led the private placement; right to designate one board member)

    Insiders: Mr. Mir Imran, the Company's executive chairman, participated

    Use of proceeds: To support continued advancement of the company's pipeline using the RaniPill platform.

    Announced Oct 17, 2025 · Closed Oct 23, 2025

  • Registered direct offering of class A common stock and pre-funded warrants

    Jul 15, 2025

    Announced: about US$3M · US$0.4 a share · Maxim Group LLC

    Dealers: Maxim Group LLC (lead)

    Announced Jul 15, 2025

Read by 6ix AI from the company's releases

Decks

Rani Therapeutics Holdings, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 74 in all · newest Oct 13, 2026 · oldest 2021
Calls
4 calls with a replay · 4 with a transcript · latest Mar 26, 2026
Decks
9 decks · latest July 2026

Where Rani Therapeutics Holdings, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RANI · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RANIBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Rani Therapeutics Holdings, Inc.